{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T13:07:55Z","timestamp":1787836075273,"version":"build-2784847793"},"reference-count":24,"publisher":"BMJ","issue":"7","license":[{"start":{"date-parts":[[2021,7,9]],"date-time":"2021-07-09T00:00:00Z","timestamp":1625788800000},"content-version":"unspecified","delay-in-days":8,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007658","name":"Baxter Healthcare corporation","doi-asserted-by":"crossref","award":["19CECACEU1002"],"award-info":[{"award-number":["19CECACEU1002"]}],"id":[{"id":"10.13039\/100007658","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2021,6,17]]},"published-print":{"date-parts":[[2021,7]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Cytokine storm and endotoxin release during cardiac surgery with cardiopulmonary bypass (CPB) have been related to vasoplegic shock and organ dysfunction. We hypothesised that early (during CPB) cytokine adsorption with oXiris membrane for patients at high risk of inflammatory syndrome following cardiac surgery may improve microcirculation, endothelial function and outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and analysis<\/jats:title>\n                    <jats:p>The Oxicard trial is a prospective, monocentric trial, randomising 70 patients scheduled for cardiac surgery. The inclusion criterion is patients aged more than 18 years old undergoing elective cardiac surgery under CPB with an expected CPB time &gt;90 min (double valve replacement or valve replacement plus coronary arterial bypass graft). Patients will be allocated to the intervention group (n=35) or the control group (n=35). In the intervention group, oXiris membrane will be used on the Prismaflex device (Baxter) at blood pump flow of 450 mL\/min during cardiac surgery under CPB. In the control group, cardiac surgery under CPB will be conducted as usual without oXiris membrane. An intention-to-treat analysis will be performed. The primary endpoint will be the microcirculatory flow index measured by sublingual microcirculation device at day 1 following cardiac surgery. The secondary endpoints will be other microcirculation variables at CPB end, 6 hours after CPB, at day 1 and at day 2. We also aim to evaluate the occurrence of major cardiovascular and cerebral events (eg, myocardial infarction, stroke, ischaemic mesenteric, resuscitated cardiac arrest, acute kidney injury) within the first 30 days. Cumulative catecholamine use, intensive care unit length of stay, endothelium glycocalyx shedding parameters (syndecan-1, heparan-sulfate and hyaluronic acid), inflammatory cytokines (tumour necrosis factor (TNF) alpha, interleukin 1 (IL1) beta, IL 10, IL 6, lipopolysaccharide, endothelin) and endothelial permeability biomarkers (angiopoietin 1, angiopoietin 2, Tie2 soluble receptor and Vascular Endothelial Growth Factor (VEGF) will also be evaluated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Ethics and dissemination<\/jats:title>\n                    <jats:p>Ethical approval has been obtained from the Institutional Review Board of the University Hospital of Amiens (registration number ID RDB: 2019-A02437-50 in February 2020). Results of the study will be disseminated via peer-reviewed publications and presentations at national and international conferences.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration number<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"clintrialgov\" specific-use=\"clinicaltrial pre-results\" xlink:href=\"NCT04201119\">NCT04201119<\/jats:ext-link>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2020-044424","type":"journal-article","created":{"date-parts":[[2021,7,9]],"date-time":"2021-07-09T11:55:44Z","timestamp":1625831744000},"page":"e044424","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":7,"title":["Effect of the oXiris membrane on microcirculation after cardiac surgery under cardiopulmonary bypass: study protocol for a randomised controlled trial (OXICARD Study)"],"prefix":"10.1136","volume":"11","clinical-trial-number":[{"clinical-trial-number":"nct04201119","registry":"10.18810\/clinical-trials-gov","type":"preResults"},{"clinical-trial-number":"nct04201119","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Osama","family":"Abou-Arab","sequence":"first","affiliation":[{"name":"Anesthesiology and Critical Care, CHU Amiens-Picardie, Amiens, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1563-4869","authenticated-orcid":false,"given":"Pierre","family":"Huette","sequence":"additional","affiliation":[{"name":"Anesthesiology and Critical Care, CHU Amiens-Picardie, Amiens, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Haye","sequence":"additional","affiliation":[{"name":"Anesthesiology and Critical Care, CHU Amiens-Picardie, Amiens, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathieu","family":"Guilbart","sequence":"additional","affiliation":[{"name":"Anesthesiology and Critical Care, CHU Amiens-Picardie, Amiens, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilles","family":"Touati","sequence":"additional","affiliation":[{"name":"Cardiac Surgery Department, CHU Amiens-Picardie, Amiens, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Momar","family":"Diouf","sequence":"additional","affiliation":[{"name":"Statistic Department, CHU Amiens-Picardie, Amiens, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Beyls","sequence":"additional","affiliation":[{"name":"Anesthesiology and Critical Care, CHU Amiens-Picardie, Amiens, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herve","family":"Dupont","sequence":"additional","affiliation":[{"name":"Anesthesiology and Critical Care, CHU Amiens-Picardie, Amiens, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yazine","family":"Mahjoub","sequence":"additional","affiliation":[{"name":"Anesthesiology and Critical Care, CHU Amiens-Picardie, Amiens, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2021,7,9]]},"reference":[{"key":"2025121601253000000_11.7.e044424.1","doi-asserted-by":"publisher","DOI":"10.1053\/j.jvca.2017.10.032"},{"key":"2025121601253000000_11.7.e044424.2","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1007\/s00134-016-4666-z","article-title":"Monitoring dynamic arterial elastance as a means of decreasing the duration of norepinephrine treatment in vasoplegic syndrome following cardiac surgery: a prospective, randomized trial","volume":"43","author":"Guinot","year":"2017","journal-title":"Intensive Care Med"},{"key":"2025121601253000000_11.7.e044424.3","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-200207000-00030"},{"key":"2025121601253000000_11.7.e044424.4","doi-asserted-by":"publisher","DOI":"10.1186\/cc3809"},{"key":"2025121601253000000_11.7.e044424.5","doi-asserted-by":"publisher","DOI":"10.1097\/01.anes.0000291442.69337.c9"},{"key":"2025121601253000000_11.7.e044424.6","doi-asserted-by":"crossref","first-page":"e154","DOI":"10.1097\/CCM.0000000000002064","article-title":"Effect of RBC transfusion on sublingual microcirculation in hemorrhagic shock patients: a pilot study","volume":"45","author":"Tanaka","year":"2017","journal-title":"Crit Care Med"},{"key":"2025121601253000000_11.7.e044424.7","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/j.bja.2018.05.049","article-title":"Vasculotide, an angiopoietin-1 mimetic, reduces pulmonary vascular leakage and preserves microcirculatory perfusion during cardiopulmonary bypass in rats","volume":"121","author":"Dekker","year":"2018","journal-title":"Br J Anaesth"},{"key":"2025121601253000000_11.7.e044424.8","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.00397.2014"},{"key":"2025121601253000000_11.7.e044424.9","doi-asserted-by":"crossref","first-page":"141","DOI":"10.5301\/ijao.5000492","article-title":"Treatment of post-cardiopulmonary bypass SIRS by hemoadsorption: a case series","volume":"39","author":"Tr\u00e4ger","year":"2016","journal-title":"Int J Artif Organs"},{"key":"2025121601253000000_11.7.e044424.10","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1159\/000499589","article-title":"Continuous renal replacement therapy with the Adsorbing filter oXiris in septic patients: a case series","volume":"47 Suppl 3","author":"Turani","year":"2019","journal-title":"Blood Purif"},{"key":"2025121601253000000_11.7.e044424.11","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s40635-018-0177-2","article-title":"In vitro comparison of the adsorption of inflammatory mediators by blood purification devices","volume":"6","author":"Malard","year":"2018","journal-title":"Intensive Care Med Exp"},{"key":"2025121601253000000_11.7.e044424.12","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/s13054-016-1270-0","article-title":"Effect of hemoadsorption during cardiopulmonary bypass surgery - a blinded, randomized, controlled pilot study using a novel adsorbent","volume":"20","author":"Bernardi","year":"2016","journal-title":"Crit Care"},{"key":"2025121601253000000_11.7.e044424.13","first-page":"79","article-title":"EACTS\/EACTA guidelines on patient blood management for adult cardiac surgery","volume":"2018","author":"Pagano","year":"2017","journal-title":"Eur J Cardiothorac Surg"},{"key":"2025121601253000000_11.7.e044424.14","doi-asserted-by":"publisher","DOI":"10.1093\/ejcts\/ezs043"},{"key":"2025121601253000000_11.7.e044424.15","doi-asserted-by":"publisher","DOI":"10.1097\/EJA.0000000000000118"},{"key":"2025121601253000000_11.7.e044424.16","doi-asserted-by":"publisher","DOI":"10.1159\/000339789"},{"key":"2025121601253000000_11.7.e044424.17","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehy462"},{"key":"2025121601253000000_11.7.e044424.18","first-page":"607","article-title":"French legal approach to clinical research","volume":"37","author":"Toulouse","year":"2018","journal-title":"Anaesth Crit Care Pain Med"},{"key":"2025121601253000000_11.7.e044424.19","doi-asserted-by":"crossref","first-page":"100","DOI":"10.4103\/0976-500X.72352","article-title":"Statement: updated guidelines for reporting parallel group randomised trials","volume":"2010","author":"Schulz","year":"2010","journal-title":"J Pharmacol Pharmacother"},{"key":"2025121601253000000_11.7.e044424.20","doi-asserted-by":"crossref","first-page":"2766","DOI":"10.1053\/j.jvca.2019.12.013","article-title":"Vasoplegia during cardiopulmonary bypass: current literature and rescue therapy options","volume":"34","author":"Ortoleva","year":"2020","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"2025121601253000000_11.7.e044424.21","doi-asserted-by":"publisher","DOI":"10.1038\/nri2171"},{"key":"2025121601253000000_11.7.e044424.22","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1111\/anae.14577","article-title":"Postoperative microcirculatory perfusion and endothelial glycocalyx shedding following cardiac surgery with cardiopulmonary bypass","volume":"74","author":"Dekker","year":"2019","journal-title":"Anaesthesia"},{"key":"2025121601253000000_11.7.e044424.23","doi-asserted-by":"publisher","DOI":"10.1016\/j.athoracsur.2009.07.002"},{"key":"2025121601253000000_11.7.e044424.24","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1159\/000503775","article-title":"Microcirculation: physiology, pathophysiology, and clinical application","volume":"49","author":"Guven","year":"2020","journal-title":"Blood Purif"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2020-044424","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T09:25:43Z","timestamp":1765877143000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2020-044424"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":24,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2021,7,9]]},"published-print":{"date-parts":[[2021,7]]}},"alternative-id":["10.1136\/bmjopen-2020-044424"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2020-044424","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7]]}}}